{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T01:05:18Z","timestamp":1762045518609},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.arbres.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T22:07:29Z","timestamp":1522966049000},"page":"414-419","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["\u00d3xido n\u00edtrico alveolar y bronquial en la enfermedad pulmonar obstructiva cr\u00f3nica y el solapamiento de asma y EPOC (ACO)"],"prefix":"10.1016","volume":"54","author":[{"given":"Bernardino","family":"Alc\u00e1zar-Navarrete","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Castellano Mi\u00f1\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Santiago D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliveiro","family":"Ruiz Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro J.","family":"Romero Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2018.02.006_bib0185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.arbres.2017.02.001","article-title":"Informe 2017 de la iniciativa global para el diagn\u00f3stico, tratamiento y prevenci\u00f3n de la enfermedad pulmonar obstructiva cr\u00f3nica: Resumen ejecutivo de GOLD","volume":"53","author":"Vogelmeier","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2018.02.006_bib0190","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.arbres.2017.03.018","article-title":"Gu\u00eda espa\u00f1ola de la enfermedad pulmonar obstructiva cr\u00f3nica (GesEPOC) 2017, Tratamiento farmacol\u00f3gico en fase estable","volume":"53","author":"Miravitlles","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2018.02.006_bib0195","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1056\/NEJMra0804752","article-title":"Immunologic aspects of chronic obstructive pulmonary disease","volume":"360","author":"Cosio","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2018.02.006_bib0200","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2018.02.006_bib0205","first-page":"49","article-title":"Diagnosis of asthma\u2013COPD overlap: the five commandments","author":"Miravitlles","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2018.02.006_bib0210","first-page":"10","article-title":"What pulmonologists think about the asthma\u2013COPD overlap syndrome","author":"Miravitlles","year":"2015","journal-title":"Int J COPD"},{"key":"10.1016\/j.arbres.2018.02.006_bib0215","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1183\/13993003.00436-2016","article-title":"What is asthma?.COPD overlap syndrome? Towards a consensus definition from a round table discussion","volume":"48","author":"Sin","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2018.02.006_bib0220","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.arbres.2017.04.002","article-title":"Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA)","volume":"53","author":"Plaza","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2018.02.006_bib0225","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1152\/jappl.1998.85.2.653","article-title":"A two-compartment model of pulmonary nitric oxide exchange dynamics","volume":"85","author":"Tsoukias","year":"1998","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.arbres.2018.02.006_bib0230","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1378\/chest.13-0843","article-title":"A novel approach to partition central and peripheral airway nitric oxide","volume":"145","author":"Paredi","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2018.02.006_bib0235","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1152\/japplphysiol.00533.2006","article-title":"A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model","volume":"102","author":"Condorelli","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.arbres.2018.02.006_bib0240","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1183\/09031936.06.00087905","article-title":"Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma","volume":"27","author":"van Veen","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2018.02.006_bib0245","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/rr83","article-title":"Small airway inflammation in asthma","volume":"2","author":"Tulic","year":"2001","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2018.02.006_bib0250","doi-asserted-by":"crossref","first-page":"47114","DOI":"10.1088\/1752-7155\/9\/4\/047114","article-title":"Extended nitric oxide analysis may improve personalized anti-inflammatory treatment in asthmatic children with intermediate F E NO 50","volume":"9","author":"Thornadtsson","year":"2015","journal-title":"J Breath Res"},{"key":"10.1016\/j.arbres.2018.02.006_bib0255","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.arbres.2014.07.005","article-title":"Patrones inflamatorios en ni\u00f1os asm\u00e1ticos basados en la determinaci\u00f3n de \u00f3xido n\u00edtrico alveolar","volume":"51","author":"Corcuera-Elosegui","year":"2015","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2018.02.006_bib0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.niox.2016.02.003","article-title":"Diagnostic performance of the measurement of nitric oxide in exhaled air in the diagnosis of COPD phenotypes","volume":"54","author":"Alc\u00e1zar-Navarrete","year":"2016","journal-title":"Nitric Oxide - Biol Chem"},{"key":"10.1016\/j.arbres.2018.02.006_bib0265","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/COPD.S44552","article-title":"Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study","volume":"9","author":"Donohue","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2018.02.006_bib0270","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00408-014-9591-8","article-title":"Exhaled nitric oxide predicts eosinophilic airway inflammation in COPD","volume":"192","author":"Chou","year":"2014","journal-title":"Lung"},{"key":"10.1016\/j.arbres.2018.02.006_bib0275","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s10753-013-9653-8","article-title":"Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide","volume":"36","author":"Soter","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.arbres.2018.02.006_bib0280","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1440-1843.2010.01711.x","article-title":"Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations","volume":"15","author":"Antus","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.arbres.2018.02.006_bib0285","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3346\/jkms.2017.32.3.439","article-title":"Relationship between fractional exhaled nitric oxide level and efficacy of inhaled corticosteroid in asthma-COPD overlap syndrome patients with different disease severity","volume":"32","author":"Feng","year":"2017","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.arbres.2018.02.006_bib0290","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1183\/09031936.04.00125304","article-title":"Exhaled nitric oxide from lung periphery is increased in COPD","volume":"26","author":"Brindicci","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2018.02.006_bib0295","doi-asserted-by":"crossref","unstructured":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-30.","DOI":"10.1164\/rccm.200406-710ST"},{"key":"10.1016\/j.arbres.2018.02.006_bib0300","doi-asserted-by":"crossref","first-page":"1600965","DOI":"10.1183\/13993003.00965-2016","article-title":"A European Respiratory Society technical standard: exhaled biomarkers in lung disease","volume":"49","author":"Horv\u00e1th","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2018.02.006_bib0305","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.arbres.2013.04.001","article-title":"Espirometr\u00eda","volume":"49","author":"Garc\u00eda-R\u00edo","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2018.02.006_bib0310","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2018.02.006_bib0315","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.05.00035005","article-title":"Standardisation of the measurement of lung volumes","volume":"26","author":"Wanger","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2018.02.006_bib0320","doi-asserted-by":"crossref","first-page":"1600016","DOI":"10.1183\/13993003.00016-2016","article-title":"2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung","volume":"49","author":"Graham","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2018.02.006_bib0325","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1183\/09031936.00048513","article-title":"Domiciliary diurnal variation of exhaled nitric oxide fraction for asthma control","volume":"43","author":"Saito","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2018.02.006_bib0330","first-page":"CD011440","article-title":"Exhaled nitric oxide levels to guide treatment for adults with asthma","volume":"9","author":"Petsky","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arbres.2018.02.006_bib0335","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1465-9921-11-47","article-title":"Clinical patterns in asthma based on proximal and distal airway nitric oxide categories","volume":"11","author":"Puckett","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2018.02.006_bib0340","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.rmed.2011.03.015","article-title":"Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD","volume":"105","author":"Bazeghi","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2018.02.006_bib0345","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1378\/chest.09-1522","article-title":"Central and peripheral airway sites of nitric oxide gas exchange in COPD","volume":"137","author":"Gelb","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2018.02.006_bib0350","doi-asserted-by":"crossref","first-page":"e0157019","DOI":"10.1371\/journal.pone.0157019","article-title":"Effect of inhaled \u03b22-agonist on exhaled nitric oxide in chronic obstructive pulmonary disease","volume":"11","author":"Amer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.arbres.2018.02.006_bib0355","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.2147\/COPD.S138540","article-title":"Small airways disease: time for a revisit?","volume":"12","author":"Stockley","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2018.02.006_bib0360","doi-asserted-by":"crossref","first-page":"e0178112","DOI":"10.1371\/journal.pone.0178112","article-title":"Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids","volume":"12","author":"Sonnappa","year":"2017","journal-title":"PLoS One"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289618300607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289618300607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T14:34:34Z","timestamp":1533134074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289618300607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0300289618300607"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2018.02.006","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00d3xido n\u00edtrico alveolar y bronquial en la enfermedad pulmonar obstructiva cr\u00f3nica y el solapamiento de asma y EPOC (ACO)","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}